Leishmania major infection in interleukin-4 and interferon-γ depleted mice

Parasite Immunology

Volumn 21, Issue 8, 1999, Pages 423-431

  Chatelain, René ^b,c   Mauze, Smita ^a   Varkila, Kari ^a,c   Coffman, Robert L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytokines; Experimental Leishmania major infection; T helper subsets

Indexed keywords

GAMMA INTERFERON; INTERFERON ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HELPER CELL; IMMUNE RESPONSE; INFECTION CONTROL; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; ANTIGENS, PROTOZOAN; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TIME FACTORS;

ANIMALIA; LEISHMANIA MAJOR; MURINAE; PROTOZOA;

EID: 0032858588     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.1999.00240.x     Document Type: Article

References (45)

1. Abrams J.S. & Pearce M.K. (1988) Development of rat anti-mouse interleukin 3 monoclonal antibodies which neutralize bioactivity in vitro. Journal of Immunology 140, 131-137
2. Abrams J.S., Roncarolo M.G., Yssel H. et al. (1992) Strategies of anti-cytokine antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunological Reviews 127, 5-24
3. Belosevic M., Finbloom D.S., Van Der Meide P.H., Slayter M.V. & Nacy C.A. (1989) Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates resistance of C3H/HeN mice to infection with Leishmania major. Journal of Immunology 143, 266-274
4. Chatelain R., Varkila K. & Coffman R.L. (1992) IL-4 induces a Th2 response in Leishmania major infected mice. Journal of Immunology 148, 1182-1187
5. Chatelain R., Mauze S., Coffman R.L. (1999) Experimental Leishmania major infection in mice: the role of IL-10. Parasite Immunol (in press)
6. Cherwinski H.M., Schumacher J.H., Brown K.D. & Mosmann T.R. (1987) Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. Journal of Experimental Medicine 166, 1229-1244
7. Coffman R.L. & Carty J. (1986) A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. Journal of Immunology 136, 949-954
8. + T-cell subset differentiation. Research in Immunology 142, 36-39
9. + T cell subsets in vivo. Immunological Reviews 123, 189-207
10. + T cell cultures. European Journal of Immunology 26, 1565-1570
11. Green S.J., Nacy C.A. & Meltzer M.S. (1991) Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. Journal of Leucocyte Biology 50, 93-103
12. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L. & Locksley R.M. (1989) Reciprocal expression of interferon gamma or IL4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169, 59-72
13. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Science USA 88, 7011-7015
14. Heinzel F.P., Schoenhaut D.S., Rerko R.M., Rosser L.E. & Gately M.K. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. Journal of Experimental Medicine 177, 1505-1509
15. Heinzel F.P., Rerko R.M., Ahmed F. & Pearlman E. (1995) Endogenous IL-12 is required for control of Th2 cytokine response capable of exacerbating leishmaniasis in normally resistant mice. Journal of Immunology 155, 730-739
16. Howard J.G. (1986) Immunological regulation and control of experimental leishmaniasis. International Reviews of Experimental Pathology 28, 79-116
17. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549
18. Kopf M., Brombacher F., Köhler G. et al. (1996) IL-4 deficient BALB/c mice resist infection with Leishmania major. Journal of Experimental Medicine 184, 1127-1136
19. Leal L.M.C.C., Moss D.W., Kühn R., Müller W. & Liew F.Y. (1993) Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. European Journal of Immunology 23, 566-569
20. Leiby D.A., Schreiber R.D. & Nacy C.A. (1993) IFNγ produced in vivo during the first two days is critical for resolution of murine Leishmania major infections. Microbial Pathogenesis 14, 495-500
21. Locksley R.M., Reiner S.L., Hatman F., Littman D.R. & Killeen N. (1993) Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice. Science 261, 1448-1451
22. Mauël J., Betz-Corradin S. & Buchmüller-Rouiller Y. (1991) Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Research in Immunology 142, 577-580
23. McKnight A.J., Zimmer G.J., Fogelman I., Wolf S.F. & Abbas A.K. (1994) Effects of IL-12 on helper T cell-dependent immune responses in vivo. Journal of Immunology 152, 2172-2179
24. + T cells. Immunology and Cell Biology 66, 57-63
25. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A. & Coffman R.L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136, 2348-2357
26. Noben-Trauth N., Kropf P. & Müller I. (1996) Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271, 987-990
27. Ohara J. & Paul W.E. (1985) Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor 1. Nature 315, 333-336
28. Powrie F., Menon S. & Coffman R.L. (1993) Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. European Journal of Immunology 23, 2223-2229
29. Reiner S.L. & Locksley R.L. (1995) The regulation of immunity to Leishmania major. Annual Reviews in Immunology 13, 151-177
30. + T cells during initiation of infection. Journal of Experimental Medicine 179, 447-456
31. Sadick M.D., Locksley R.M., Tubbs C. & Raff H.V. (1986) Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-γ in response to leishmania antigens in vitro. Journal of Immunology 136, 655-661
32. Sadick M.D., Heinzel F.P., Holaday B.J. et al. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. Journal of Experimental Medicine 171, 115-127
33. Sadick M.D., Street N., Mosmann T.R. & Locksley R.M. (1991) Cytokine regulation of murine leishmaniasis: interleukin 4 is not sufficient to mediate progressive disease in resistant C57BL/6 mice. Infection and Immunity 59, 4710-4714
34. Scharton-Kersten T., Afonso L.C., Wysocka M., Trinchieri G. & Scott P. (1995) IL-12 is required for natural killer cell activation and subsequent T helper I cell development in experimetal leishmaniasis. Journal of Immunology 154, 1995
35. Scott P. (1991) IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 147, 3149-3155
36. Scott P., Natovitz P., Coffman R.L., Pearce E. & Sher A. (1988) Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine 168, 1675-1684
37. + T cell subsets in the regulation of parasite immunity and disease. Immunological Reviews 112, 161-182
38. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proceedings of the National Academy of Science USA 90, 10188-10192
39. + T cell response. Journal of Experimental Medicine 181, 961-971
40. Sypek J.P., Chung C.L., Mayor S.E.H. et al. (1993) Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. Journal of Experimental Medicine 177, 1797-1802
41. Titus R.G., Ceredig R., Cerottini J.C. & Louis J.A. (1985) Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. Journal of Immunology 135, 2108-2113
42. Varkila K., Chatelain R., Leal L.M.C.C. & Coffman R.L. (1993) Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a Th1 response and renders them capable of healing Leishmania major infection. European Journal of Immunology 23, 262-268
43. Wang Z.E., Reiner S.L., Hatam F. et al. (1993) Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. Journal of Immunology 151, 2077-2086
44. + effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. Journal of Experimental Medicine 179, 1367-1371
45. Wang Z.E., Zheng S., Corry D.B. et al. (1994b) Interferon γ-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proceedings of the National Academy of Science USA 91, 12932-12936